Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
08/07/2003 | WO2002052023A3 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
08/07/2003 | WO2002038748A3 Mammalian sex selection using genetic modification |
08/07/2003 | WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
08/07/2003 | WO2002020850A3 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
08/07/2003 | WO2002016559A3 In vivo animal model of human leukemia |
08/07/2003 | WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
08/07/2003 | US20030150007 Method of generating transgenic organisms using transposons |
08/07/2003 | US20030150006 Gene transfer in poultry by introduction of embryo cells in ovo |
08/07/2003 | US20030150005 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
08/07/2003 | US20030150002 Generating transgenic, disease resistant cattle using cryopresevred regenerated mammalian oocytes |
08/07/2003 | US20030150001 Generating animal models using N-ethyl-N- nitrosourea (ENU) |
08/07/2003 | US20030150000 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom |
08/07/2003 | US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
08/07/2003 | US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition |
08/07/2003 | US20030149996 Method for producing polyclonal and monoclonal antibodies |
08/07/2003 | US20030149995 Compound screening methods |
08/07/2003 | US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
08/07/2003 | US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication |
08/07/2003 | US20030148978 Oligonucleotides antisense to mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation |
08/07/2003 | US20030148977 Delivering to mammalian cell that overexpresses pituitary tumor transforming gene carboxy-terminal (PTTG-C) formulation comprising polynucleotide to allow the polynucleotide to enter the cell, whereby expression of PTTG protein is prevented |
08/07/2003 | US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells |
08/07/2003 | US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
08/07/2003 | US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them |
08/07/2003 | US20030148392 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening |
08/07/2003 | US20030148389 Schizophrenia related gene and protein |
08/07/2003 | US20030148356 Amyloid precursor protein (APP); secretases |
08/07/2003 | US20030147892 Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides |
08/07/2003 | US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
08/07/2003 | US20030147873 Cell culture prodcut for treating a behavioral or psychological disorders and brian disorders, brain transplant; stem cells |
08/07/2003 | CA2480012A1 Chimeric bird from embryonic stem cells |
08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
08/07/2003 | CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
08/07/2003 | CA2474590A1 Treatment of male sexual dysfunction |
08/07/2003 | CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them |
08/07/2003 | CA2474007A1 Transgenic animals expressing prkag3 |
08/07/2003 | CA2474005A1 Prkag3 gene promoter and uses thereof |
08/07/2003 | CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase |
08/07/2003 | CA2470195A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
08/06/2003 | EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
08/06/2003 | EP1332122A1 Improved organic material treatment apparatus, system and method |
08/06/2003 | EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation |
08/06/2003 | EP1241933A4 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
08/06/2003 | EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
08/06/2003 | CN1434921A T2R taste receptors and genes encoding same |
08/06/2003 | CN1434727A Anglogenesis and vascular permeability modulators and inhibitors |
08/06/2003 | CN1434679A High temperature cryogenic preservation of biolcally active material |
08/06/2003 | CN1434678A Controlling offsprings sex ratio by targeting transgenes onto the sex chromosomes |
08/05/2003 | US6603057 Disruption in genomic DNA fragment; tumorigenesis and propensity to ulcerative colitis; replacement with a neomycin gene under the control of phospholipid kinase; use in prevention and treatment of tumors; drug screening |
08/05/2003 | US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage |
08/05/2003 | US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals |
08/05/2003 | US6602277 Methods and devices for manipulating the themoregulatory status of a mammal |
08/05/2003 | CA2202549C Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene |
07/31/2003 | WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor |
07/31/2003 | WO2003062415A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
07/31/2003 | WO2003062394A2 Methods and compositions for rna interference |
07/31/2003 | WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof |
07/31/2003 | WO2003062173A2 Alanine 2,3- aminomutase |
07/31/2003 | WO2003061591A2 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
07/31/2003 | WO2003041659A3 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders |
07/31/2003 | WO2002101005A3 A g-protein coupled receptor and uses therefor |
07/31/2003 | WO2002096192A3 Process of producing environmentally safe transgenic organisms |
07/31/2003 | WO2002019814A3 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety |
07/31/2003 | WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
07/31/2003 | US20030145343 Transgenic animals expressing human p25 |
07/31/2003 | US20030145342 Activation; transgenic rodent; genetic engineering |
07/31/2003 | US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
07/31/2003 | US20030145340 Ballistic transformation of C. elegans |
07/31/2003 | US20030145339 Peptide production |
07/31/2003 | US20030144482 Diagnosis of skin cancer; vaccine |
07/31/2003 | US20030144239 Expression system |
07/31/2003 | US20030144232 Expression system |
07/31/2003 | US20030144176 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
07/31/2003 | US20030143737 Long-term cell-culture compositions and genetically modified animals derived therefrom |
07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
07/31/2003 | US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein |
07/31/2003 | US20030143679 Genes encoding insect odorant receptors and uses thereof |
07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
07/31/2003 | US20030143531 Detection and quantification of microorganisms using amplification and restriction enzyme analysis |
07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
07/31/2003 | CA2474030A1 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
07/31/2003 | CA2473944A1 Methods and compositions for rna interference |
07/31/2003 | CA2473716A1 Alanine 2,3- aminomutase |
07/30/2003 | EP1330645A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
07/30/2003 | EP1207751A4 Non-mammalian transgenic animal model for cellular proliferative diseases |
07/30/2003 | EP1130960A4 Transgenic animals |
07/30/2003 | EP0983074B1 Non-myeloablative tolerogenic treatment |
07/30/2003 | CN2562581Y Bamboo made check cocooning tool |
07/30/2003 | CN2562580Y Stereo square shape through type artificial reef |
07/30/2003 | CN1433475A Biological control by conditional dominant lethal genetic system |
07/30/2003 | CN1432273A Artificial wasp domesticating breeding technology |
07/29/2003 | US6600087 Propagation of cattle embryo; obtain fetal tissue, extract nucleus, transfer nucleus to oocyte, activate cytoplasm complex, propagate cells, implant cells into cattle, allow fetus to propagate |
07/29/2003 | CA2067136C Growth hormone antagonists |
07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
07/24/2003 | WO2003060124A1 NOVEL PROTEINS PARTICIPATING IN STRESS RESPONSE VIA THE ACTIVATION OF p38 MAPK AND GENES THEREOF |
07/24/2003 | WO2003060101A2 Gene delivery system and methods of use |